We generated human leukemia THP-1 and breast cancer MDA-MB-231 USP18+/− (He) and USP18−/− (KO) cells and observed higher IFN signaling, DNA-damage response, and annexin V+ cells upon IFN treatment (Fig. 4a–c). The gene discussed is USP18; the disease is leukemia.